Biotech Week articles from July 2003

Biotech Week archives from July 2003

Technique exploits aptamer-gp120 interactions to identify new antiretrovirals.
July 2, 2003... 2003 JUL 2 - (NewsRx.com & NewsRx.net) -- Researchers in Oxford University's Sir William Dunn School of Pathology have developed a novel high throughput screening (HTS) technique for identifying antiretroviral agents/drugs that inhibit HIV...

IV infusions of human umbilical cord blood stem cells benefit rodents with ALS.
July 2, 2003... 2003 JUL 2 - (NewsRx.com & NewsRx.net) -- Stem cells derived from human umbilical cord blood (HUCB) migrate to damaged areas in the brain and spinal cord caused by disease or injury and provide some therapeutic benefit, according to results of...

Antitumor activity reported for ABI-007 in patients resistant to taxane.
July 2, 2003... 2003 JUL 2 - (NewsRx.com & NewsRx.net) -- At the recent American Society of Clinical Oncology (ASCO) meeting, American Pharmaceutical Partners, Inc., (APPX) said investigators reported on the early findings in a phase II metastatic breast...

Initial clinical data reported from phase I/II trial of GVAX vaccine.
July 2, 2003... 2003 JUL 2 - (NewsRx.com & NewsRx.net) -- Cell Genesys, Inc., (CEGE) reported initial clinical data from a phase I/II trial of GVAX cancer vaccine for multiple myeloma, a type of bone marrow cancer, as well as positive interim results on a...

Pioglitazone improves glycemic control and lipid profiles in type 2 diabetes.
July 2, 2003... 2003 JUL 2 - (NewsRx.com & NewsRx.net) -- by Maria G. Essig, MS, ELS, senior medical writer - Results from a randomized, double-blind, placebo-controlled, clinical trial involving 41 centers in Canada and Spain demonstrated that pioglitazone...

Final results of phase IIa kidney transplant trial announced.
July 2, 2003... 2003 JUL 2 - (NewsRx.com & NewsRx.net) -- Isotechnika, Inc., announced that the company presented the final results of its phase IIa kidney transplant study at the American Transplant Congress in Washington, DC. Designed to evaluate...

Private placement funds will further develop stem cell technology.
July 2, 2003... 2003 JUL 2 - (NewsRx.com & NewsRx.net) -- A.I. Software, Inc., (ASOW) announced that a private placement of securities has raised gross proceeds of $861,500, which will be used to help fund continuing development of its stem cell expansion...

Neovastat phase III trials status presented.
July 2, 2003... 2003 JUL 2 - (NewsRx.com & NewsRx.net) -- Bernard Escudier, head of the Immunotherapy Unit at Institut Gustave-Roussy in Paris, France, and lead investigator in Europe for AEterna Laboratories (AELA; AEL) Neovastat phase III trial in renal cell...

Angiogenesis quantification needs streamlining if predictive value is the goal.
July 2, 2003... 2003 JUL 2 - (NewsRx.com & NewsRx.net) -- Angiogenesis quantification needs streamlining if predictive value is the goal. "Chalkley counts have been suggested as the primary method for immunohistochemical evaluation of angiogenesis,...

Angiogenesis inhibitor demonstrates no dose-limiting toxicities.
July 2, 2003... 2003 JUL 2 - (NewsRx.com & NewsRx.net) -- Data from a phase I study of ABT-510, Abbott Laboratories' (ABT) investigational angiogenesis inhibitor, were presented at the American Society of Clinical Oncology (ASCO) meeting and indicated that...

Brain cancer therapy yields positive response in early trials.
July 2, 2003... 2003 JUL 2 - (NewsRx.com & NewsRx.net) -- Accelerate Brain Cancer Cure (ABC2), a non-profit foundation dedicated to accelerating therapies leading to a cure for brain cancer, commented on Genentech's phase I brain cancer clinical trial data...

Combination of two companies will increase drug discovery capabilities.
July 2, 2003... 2003 JUL 2 - (NewsRx.com & NewsRx.net) -- Actelion, Ltd., and Discovery Partners International, Inc., (DPII) announced that the two companies have signed a 3-year collaborative agreement whereby Actelion will procure drug discovery capabilities...

Company announces follow on finance to undertake vaccination initiative.
July 2, 2003... 2003 JUL 2 - (NewsRx.com & NewsRx.net) -- Adjuvantix Limited, a Sheffield, U.K., based vaccine adjuvant company, announced the completion of a further investment from the White Rose Technology Seedcorn Fund (WRTSF), bringing its total funding...

Enrollment for alvimopan phase III study completed.
July 2, 2003... 2003 JUL 2 - (NewsRx.com & NewsRx.net) -- Adolor Corporation (ADLR) announced completion of enrollment in its phase III clinical trial (POI 14CL313) studying the use of the company's product candidate, alvimopan, for the management of...

New microchip technology gives artificial limb users more movement.
July 2, 2003... 2003 JUL 2 - (NewsRx.com & NewsRx.net) -- Advanced Control Research Ltd. (ACR), U.K., is developing a new microchip system that will give prosthetic arm users more movement and control of their artificial limbs thanks to an Invention &...

HIPK1 may play a role in tumorigenesis, perhaps by regulating p53, Mdm2, or both.
July 2, 2003... 2003 JUL 2 - (NewsRx.com & NewsRx.net) -- HIPK1 may play a role in tumorigenesis, perhaps by regulating p53 and/or Mdm2. "The tumor suppressor p53 is regulated in part by binding to cellular proteins. We used p53 as bait in the yeast...

Genomics company to support AAAS prize.
July 2, 2003... 2003 JUL 2 - (NewsRx.com & NewsRx.net) -- Affymetrix, Inc., (AFFX) and the American Association for the Advancement of Science (AAAS) announced Affymetrix' support of the AAAS Newcomb Cleveland Prize. The prize recognizes outstanding...

National organizations applaud educational initiative.
July 2, 2003... 2003 JUL 2 - (NewsRx.com & NewsRx.net) -- The National Association of AIDS Education & Training Centers (NAAETC) and the American Public Health Association applauded the launch of "Dialogues: Education and Treatment for a Well Planned Future,"...

VEGF has clinical significance in the pathogenesis of papillary thyroid cancer.
July 2, 2003... 2003 JUL 2 - (NewsRx.com & NewsRx.net) -- VEGF has clinical significance in the pathogenesis of papillary thyroid cancer. According to a study from Turkey, "vascular endothelial growth factor (VEGF) is a major regulator of angiogenesis and...

Leptin's effect on insulin secretion mediated through central mechanisms.
July 2, 2003... 2003 JUL 2 - (NewsRx.com & NewsRx.net) -- The physiologic effect of leptin on insulin secretion is mediated mainly through central mechanisms. According to recent research from the United States, "Leptin has been shown to decrease...

Pharmaceuticals company reports reduced revenues.
July 2, 2003... 2003 JUL 2 - (NewsRx.com & NewsRx.net) -- Alexion Pharmaceuticals, Inc., (ALXN) announced financial results for its third fiscal quarter and 9 months ended April 30, 2003. For the third quarter ended April 30, 2003, Alexion reported...

S29 ribosomal protein sensitizes H520 cells to chemotherapy in lung cancer.
July 2, 2003... 2003 JUL 2 - (NewsRx.com & NewsRx.net) -- S29 ribosomal protein sensitizes H520 cells to chemotherapy in lung cancer. "Non-small cell lung cancer (NSCLC) is the most prevalent type of lung cancer especially in India and displays resistance...

Study shows strong treatment for ovarian cancer.
July 2, 2003... 2003 JUL 2 - (NewsRx.com & NewsRx.net) -- AltaRex Corp. (TSX: AXO, OTC: ALXFF) announced the results of a phase II trial of OvaRex (oregovamab) at the annual meeting of the American Society of Clinical Oncologists (ASCO). The results of...

Stent company names physician advisory board.
July 2, 2003... 2003 JUL 2 - (NewsRx.com & NewsRx.net) -- Alveolus announced the formation of a physician advisory board to lead the company's development and introduction of gastrointestinal stenting products in 2004. The physician board of advisors is...

Low-dose interferon alpha lozenges to be used against SARS.
July 2, 2003... 2003 JUL 2 - (NewsRx.com & NewsRx.net) -- Amarillo Biosciences, Inc., (AMAR), a U.S. pharmaceutical research and development firm, is taking new steps to help combat the spread of severe acute respiratory syndrome (SARS) in Asia. The...

Revenues drop 81% for neurology pharmaceutical company.
July 2, 2003... 2003 JUL 2 - (NewsRx.com & NewsRx.net) -- Amarin Corporation plc (AMRN) reported that, after taking additional provisions of $7.3 million for Permax due to the market entry of generic pergolide, revenues fell by 81% to $3.3 million for the...

Endocrinologists concerned for menopausal women.
July 2, 2003... 2003 JUL 2 - (NewsRx.com & NewsRx.net) -- The American Association of Clinical Endocrinologists (AACE) is concerned that widespread media coverage of new studies published in The Journal of the American Medical Association (JAMA) may cause...

Data suggest risk of infection doubles with reduced Neupogen administration.
July 2, 2003... 2003 JUL 2 - (NewsRx.com & NewsRx.net) -- Amgen (AMGN) announced data from several studies presented at the American Society of Clinical Oncology (ASCO) meeting evaluating the impact of optimal usage of Neupogen (Filgrastim) to help facilitate...

Gene therapy may help treat disorder that leads to diabetes.
July 2, 2003... 2003 JUL 2 - (NewsRx.com & NewsRx.net) -- Amsterdam Molecular Therapeutics B.V., Amsterdam, The Netherlands (AMT), data from its lipoprotein lipase (LPL) deficiency program at the American Society of Gene Therapy meeting in Washington, DC. ...

Symlin, exenatide highlighted at diabetes meeting.
July 2, 2003... 2003 JUL 2 - (NewsRx.com & NewsRx.net) -- Amylin Pharmaceuticals, Inc., (AMLN) announced that it planned to present more than a dozen abstracts at the 63rd Annual Scientific Sessions of the American Diabetes Association (ADA). Two...

Notice of listing qualification deficiency reported by pharmaceutical firm.
July 2, 2003... 2003 JUL 2 - (NewsRx.com & NewsRx.net) -- Antares Pharma, Inc., (ANTR) announced that it has received a notice from the NASDAQ Listing Qualifications Staff. The notice indicates that the company fails to comply with the independent...

Roth named to board of directors at biotech manufacturer.
July 2, 2003... 2003 JUL 2 - (NewsRx.com & NewsRx.net) -- AppTec Laboratory Services has named Stephen Roth, PhD, to its board of directors. Roth joins the board as the company begins construction on a new 75,200-square-foot laboratory and...

Toxoplasma gondii tachyzoite antigens elicit immune response in mice.
July 2, 2003... 2003 JUL 2 - (NewsRx.com & NewsRx.net) -- Toxoplasma gondii tachyzoite antigens elicited protective immune responses in mice. According to a study from Iran, "excretory secretory antigens (ESA) of Toxoplasma gondii were evaluated in...

Immunomodulation can also be used to combat invasive fungus.
July 2, 2003... 2003 JUL 2 - (NewsRx.com & NewsRx.net) -- Antifungals are not the only way to combat fungal infection; immunomodulation can be used. According to a study from Greece, "Genetic and acquired determinants increase the risk for invasive fungal...

Interim results presented from study of alpha 1-antitrypsin.
July 2, 2003... 2003 JUL 2 - (NewsRx.com & NewsRx.net) -- Arriva Pharmaceuticals, Inc., announced interim results from its ex vivo human studies of recombinant alpha 1-antitrypsin (rAAT) in adult and pediatric patients with middle ear disease (otitis media,...

Fatty acid analysis useful for identification.
July 2, 2003... 2003 JUL 2 - (NewsRx.com & NewsRx.net) -- Fatty acid analysis can be useful for identifying different species of mycobacteria. In a study from Turkey, "the cellular fatty acid profiles of 67 strains belonging to three different species of...

Phase I data on suberoylanilide hydroxamic acid presented.
July 2, 2003... 2003 JUL 2 - (NewsRx.com & NewsRx.net) -- Aton Pharma, Inc., announced that the abstract "Clinical Experience of the Histone Deacetylase Inhibitor Suberoylanilide Hydroxamic Acid (SAHA) in Heavily Pre-Treated Patients with Hematological...

Phase III results enhances treatment for pancreatic cancer patients.
July 2, 2003... 2003 JUL 2 - (NewsRx.com & NewsRx.net) -- The first results of the phase III trial comparing the combination of gemcitabine (Gem) and oxaliplatin (Ox) to gemcitabine alone were presented at the annual meeting of the American Society of Clinical...

Enrollment completed for Atrisone phase III studies.
July 2, 2003... 2003 JUL 2 - (NewsRx.com & NewsRx.net) -- Atrix Laboratories, Inc., (ATRX) announced that enrollment has been completed for the pivotal phase III clinical studies for Atrisone (5% dapsone topical gel) for the treatment of acne. More than...

Global manufacturing agreement signed for closure device.
July 2, 2003... 2003 JUL 2 - (NewsRx.com & NewsRx.net) -- Avail Medical Products, Inc., announced that it has entered into a global manufacturing agreement with Kinetic Concepts, Inc., (KCI) to exclusively supply all disposable product lines in KCI's Vacuum...

New chemotherapy agent highlighted in oncology studies.
July 2, 2003... 2003 JUL 2 - (NewsRx.com & NewsRx.net) -- Taxotere (docetaxel) Injection Concentrate, an active chemotherapy agent, showed positive results in various treatment regimens in early and advanced breast cancer according to numerous phase II and III...

Site-specific capsules effective for oseltamivir delivery.
July 2, 2003... 2003 JUL 2 - (NewsRx.com & NewsRx.net) -- Site-specific capsules are effective for delivery of anti-influenza medication. Scientists in the United States "investigated the site-specific absorption of oseltamivir using targeted delivery and...

Photofrin PDT studied for treatment of malignancy in ducts.
July 2, 2003... 2003 JUL 2 - (NewsRx.com & NewsRx.net) -- Axcan Pharma, Inc., announced that it will support phase II studies on the use of Photofrin photodynamic therapy (PDT) in the treatment of cholangiocarcinoma, a malignant growth in the ducts that...

Genomic rearrangements account for more than one-third of the BRCA1 mutations.
July 2, 2003... 2003 JUL 2 - (NewsRx.com & NewsRx.net) -- Genomic rearrangements account for more than one-third of the BRCA1 mutations. According to recent research from Italy, "The recent identification of major genomic rearrangements in breast and...

Hepatitis C virus infection doesn't alter survival in renal transplant patients.
July 2, 2003... 2003 JUL 2 - (NewsRx.com & NewsRx.net) -- by Sonia Nichols, senior medical writer - Pretransplantation hepatitis C virus (HCV) infection doesn't appear to shorten the survival of renal transplant recipients, researchers say. "The effect of...

Not approvable letter issued for Cenestin 0.45-mg tablets.
July 2, 2003... 2003 JUL 2 - (NewsRx.com & NewsRx.net) -- Barr Laboratories, Inc., (BRL) announced that it has received a Not Approvable Letter from the U.S. Food and Drug Administration (FDA) for the company's supplemental New Drug Application (sNDA) for...

Contract manufacturing services expanded by big pharma firm.
July 2, 2003... 2003 JUL 2 - (NewsRx.com & NewsRx.net) -- Baxter Healthcare Corporation announced plans to enhance its parenteral contract manufacturing services for pharmaceutical and biotech companies by expanding its Baxter Pharmaceutical Solutions LLC...

Trials show early signs of tolerability for RAF kinease inhibitor.
July 2, 2003... 2003 JUL 2 - (NewsRx.com & NewsRx.net) -- A novel investigational RAF kinase inhibitor showed encouraging signs when used in combination with standard chemotherapeutics, according to Phase Ib and Phase I trial data released at the annual...

Advanced glycation end products activate Smad signaling and damage organs.
July 2, 2003... 2003 JUL 2 - (NewsRx.com & NewsRx.net) -- Advanced glycation end products activate Smad signaling via TGF-beta-dependent and -independent mechanisms to promote diabetic renal and vascular disease. According to recent research published in...

Ultrasound-microbubble mediated gene transfer ameliorates renal fibrosis.
July 2, 2003... 2003 JUL 2 - (NewsRx.com & NewsRx.net) -- by Sonia Nichols, senior medical writer - Ultrasound-microbubble mediated renal cell transfection reduces renal fibrosis in study animals, according to researchers at Baylor College of Medicine in...

Gene therapy important part of cancer research.
July 2, 2003... 2003 JUL 2 - (NewsRx.com & NewsRx.net) -- A group of researchers have attempted to activate the cell death pathways to treat several kinds of cancer, according to a study presented at the annual meeting of the American Society of Gene Therapy...

Hepatitis C virus reinfection during therapy need not lead to chronicity.
July 2, 2003... 2003 JUL 2 - (NewsRx.com & NewsRx.net) -- Hepatitis C virus reinfection during therapy need not lead to chronicity. According to recent research from France, "the prevalence of antibodies against hepatitis C virus (anti-HCV) among...

New herbal drug therapy reported effective.
July 2, 2003... 2003 JUL 2 - (NewsRx.com & NewsRx.net) -- For centuries, the herb Chinese gastrodine has been used in China to treat disorders such as dizziness, headache, and even ischemic stroke. Research presented at the American Heart Association's...

Chronically infected individuals have an imbalance of cytokines to antioxidants.
July 2, 2003... 2003 JUL 2 - (NewsRx.com & NewsRx.net) -- Chronic Chagas disease sufferers have an imbalance of cytokines to antioxidants, a fact that may lead to alternate therapeutic approaches to disease. According to published research from France,...

Research shows weight gain, safety in treatment of cancer.
July 2, 2003... 2003 JUL 2 - (NewsRx.com & NewsRx.net) -- Final study data presented at the annual meeting of the American Society of Clinical Oncology confirmed that oxandrolone therapy in patients with cancer-related weight loss resulted in weight gain and...

Report shows competitive cytokine and growth factor market.
July 2, 2003... 2003 JUL 2 - (NewsRx.com & NewsRx.net) -- Niche suppliers of cytokine and growth factor products, such as immunoassay kits, reagents, and recombinant proteins, are competing well against larger companies with a more broad product line. ...

Biodefense R&D agreement signed with U.S. Army.
July 2, 2003... 2003 JUL 2 - (NewsRx.com & NewsRx.net) -- BioSante Pharmaceuticals, Inc., (BISP) announced that it has signed a Cooperative Research and Development Agreement (CRADA) with the U.S. Army's Medical Research Institute of Infectious Diseases...

Advances in xenotransplantation reported.
July 2, 2003... 2003 JUL 2 - (NewsRx.com & NewsRx.net) -- BioTransplant, Inc., (BTRNQ.OB) announced that scientists from Immerge BioTherapeutics, the company's joint venture with Novartis Pharma AG, have recently reported results from two studies highlighting...

FDA approves prefilled syringe for Avonex.
July 2, 2003... 2003 JUL 2 - (NewsRx.com & NewsRx.net) -- Biogen, Inc., (BGEN) announced that the U.S. Food and Drug Administration (FDA) has approved a new prefilled syringe for Avonex (Interferon beta-1a), designed to make treatment even more convenient for...

Adoxa now available in new 75-mg tablets.
July 2, 2003... 2003 JUL 2 - (NewsRx.com & NewsRx.net) -- Bioglan Pharmaceuticals Company announced that Adoxa (doxycycline) tablets are now available in a 75mg tablet, adding a middle-range dosage option to Bioglan's popular 50mg and 100mg tablets currently...

Coverage of medical devices sector initiated with "hold" and "buy" ratings.
July 2, 2003... 2003 JUL 2 - (NewsRx.com & NewsRx.net) -- Blaylock & Partners' equity analyst David Zimbalist has initiated coverage of the medical devices sector with a "hold" rating on Johnson & Johnson (JNJ) and a "buy" rating on Waters Corporation (WAT)....

Tenth U.S. patent issued for pressure cycling technology.
July 2, 2003... 2003 JUL 2 - (NewsRx.com & NewsRx.net) -- Boston Biomedica, Inc., (BBII) announced that the United States Patent and Trademark Office has issued Patent No. 6,569,672 to the company for the design and use of its "Pressure Cycling Reactor" for...

Data released from Taxus II trial, GERD procedure.
July 2, 2003... 2003 JUL 2 - (NewsRx.com & NewsRx.net) -- Boston Scientific Corporation (BSX) announced additional follow-up data from the company's Taxus II paclitaxel-eluting stent clinical trial and new information on an experimental procedure for patients...

Downregulation of fibronectin reduces vascular lesions in rodent retinas.
July 2, 2003... 2003 JUL 2 - (NewsRx.com & NewsRx.net) -- According to published research from the United States, "overexpression of extracellular matrix (ECM) components is closely associated with the development of vascular basement membrane (BM) thickening,...

Polyclonal Fab phage display libraries of clones to glycoproteins have diversity.
July 2, 2003... 2003 JUL 2 - (NewsRx.com & NewsRx.net) -- Polyclonal Fab phage display libraries of clones to Cryptosporidium parvum glycoproteins have diversity. "The protozoan parasite Cryptosporidium parvum is regarded as a major public health problem...

Stem cell antigen-1 reveals information about pulmonary vascular endothelium.
July 2, 2003... 2003 JUL 2 - (NewsRx.com & NewsRx.net) -- Stem cell antigen-1 reveals information about pulmonary vascular endothelium. "Although the function of the cell surface protein stem cell antigen-1 (Sca-1) has not been identified, expression of...

Agency says U.S. government was shortchanged on cancer drug.
July 2, 2003... 2003 JUL 2 - (NewsRx.com & NewsRx.net) -- U.S. federal scientists spent millions creating the cancer drug Taxol but got only a little of the money back - despite $9 billion in sales - after turning over Taxol to a pharmaceutical company,...

Pharmaceutical company launches new headache treatment.
July 2, 2003... 2003 JUL 2 - (NewsRx.com & NewsRx.net) -- Bristol-Myers Squibb Company (NYSE:BMY) has launched Excedrin Tension Headache. According to the statement, this multi-ingredient pain reliever provides relief of head, neck, and shoulder pain...

Study finds clopidogrel not effective in certain patients.
July 2, 2003... 2003 JUL 2 - (NewsRx.com & NewsRx.net) -- Researchers at Sinai Hospital of Baltimore have discovered that patients with overreactive platelets, which may be a risk factor for clotting, do not always respond to current drugs designed to decrease...

FADD interacts with methyl-CpG binding domain protein.
July 2, 2003... 2003 JUL 2 - (NewsRx.com & NewsRx.net) -- FADD interacts with methyl-CpG binding domain protein. "Fas-associated death domain protein (FADD) is an adaptor protein bridging death receptors with initiator caspases," scientists writing in the...

Melanoma mortality rates among men in central Italy unexpectedly decline.
July 2, 2003... 2003 JUL 2 - (NewsRx.com & NewsRx.net) -- Melanoma mortality rates among men in central Italy unexpectedly decline. "A registry-based study has been carried out in central Italy to investigate cutaneous melanoma incidence and mortality...

Problems and future of fitness tests in physical education reviewed.
July 2, 2003... 2003 JUL 2 - (NewsRx.com & NewsRx.net) -- The problems and future directions of physical fitness tests in physical education programs have been reviewed. "This paper aims to examine current nationwide youth fitness test programs, address...

New microfluidics LabChip system to be distributed globally.
July 2, 2003... 2003 JUL 2 - (NewsRx.com & NewsRx.net) -- Caliper Technologies Corp. (CALP) and Bio-Rad Laboratories, Inc., (BIO) announced that the companies have entered into a multiyear product development and commercialization agreement to develop and...

Cell therapy manufacturing capacity increased 100%.
July 2, 2003... 2003 JUL 2 - (NewsRx.com & NewsRx.net) -- Cambrex Corporation (CBM), a provider of cell therapy services, announced that it is constructing a new facility to accommodate four cGMP suites dedicated to cell therapy manufacturing. The...

Corporate update provided for U.K.-based biotech.
July 2, 2003... 2003 JUL 2 - (NewsRx.com & NewsRx.net) -- Peter Garland, Cambridge Antibody Technology's chairman, released the following statement: The core value of the company is in the pipeline of products derived from our exceptional technology. The...

Licensing agreement sought for microporous polyurethane-covered stent.
July 2, 2003... 2003 JUL 2 - (NewsRx.com & NewsRx.net) -- CardioTech International, Inc., (CTE) announced the conclusion of an in vivo study using a novel microporous polyurethane-encapsulated coronary artery stent. This opens a potential market of $3...

Mycobacterial taxonomy includes new, occasionally pathogenic members.
July 2, 2003... 2003 JUL 2 - (NewsRx.com & NewsRx.net) -- New mycobacterial species are often discovered clinically; although rare, they must be considered during diagnosis. According to published research from Italy, "The advancement of genetic...

Former U.S. Attorney General Edwin Meese joins Carrington board.
July 2, 2003... 2003 JUL 2 - (NewsRx.com & NewsRx.net) -- Carrington Laboratories, Inc., (CARN) announced that former U.S. Attorney General Edwin Meese III has been elected to the company's board of directors. Meese, 71, joins the existing five-member...

Cutaneous infections create challenges, but there are some available treatments.
July 2, 2003... 2003 JUL 2 - (NewsRx.com & NewsRx.net) -- Cutaneous fungal infections still create challenges, but there are some available treatments. According to recent research published in the journal Infectious Disease Clinics of North America,...

Hydrostatic pressure can enhance mesenchymal progenitor cell differentiation.
July 2, 2003... 2003 JUL 2 - (NewsRx.com & NewsRx.net) -- Hydrostatic pressure can be used to enhance mesenchymal progenitor cell differentiation in vitro. "Much attention has been given to the influences of bioactive factors on mesenchymal progenitor...

Respiratory control during sleep may be altered at the neuronal network level.
July 2, 2003... 2003 JUL 2 - (NewsRx.com & NewsRx.net) -- Upper airway occlusion and bronchoconstriction may result from abnormal neuronal function controlling respiration during sleep. "A central neuronal network regulates airway functions from the nares...

Vascular endothelial growth factor localization parallels jaw joint dysfunction.
July 2, 2003... 2003 JUL 2 - (NewsRx.com & NewsRx.net) -- Vascular endothelial growth factor localization parallels jaw joint dysfunction. According to a study from Italy, "a high density of blood vessels is found in specimens of temporomandibular joint...

Bacterial inflammatory protein linked with heart disease risk.
July 2, 2003... 2003 JUL 2 - (NewsRx.com & NewsRx.net) -- Another link between inflammation and heart disease has been reported. Chlamydia pneumoniae heat shock protein 60 (Cp-HSP60) promotes inflammation and immune responses. New study findings indicate...

TMEFF1 may behave as a tumor suppressor gene in brain cancers.
July 2, 2003... 2003 JUL 2 - (NewsRx.com & NewsRx.net) -- TMEFF1 may behave as a tumor suppressor gene in brain cancers. "TMEFF1 is a novel transmembrane protein, containing two follisatin domains and an epidermal growth factor-like region, researchers in...